title: Potential of nitroimidazoles as markers of hypoxia in heart.
authors.affiliation: Bristol-Myers Squibb Pharmaceutical Research Institute, New Brunswick, NJ 08903.
authors.forename: W L
authors.initials: WL
authors.lastname: Rumsey
authors.forename: B
authors.initials: B
authors.lastname: Patel
authors.forename: B
authors.initials: B
authors.lastname: Kuczynski
authors.forename: R K
authors.initials: RK
authors.lastname: Narra
authors.forename: Y W
authors.initials: YW
authors.lastname: Chan
authors.forename: K E
authors.initials: KE
authors.lastname: Linder
authors.forename: J
authors.initials: J
authors.lastname: Cyr
authors.forename: N
authors.initials: N
authors.lastname: Raju
authors.forename: K
authors.initials: K
authors.lastname: Ramalingam
authors.forename: A D
authors.initials: AD
authors.lastname: Nunn
mesh_terms: D000818:Animals; D015415:Biomarkers; D004285:Dogs; D000860:Hypoxia / Q000175:diagnosis / Q000378:metabolism*; D066298:In Vitro Techniques; D009206:Myocardium / Q000378:metabolism*; D009593:Nitroimidazoles / Q000493:pharmacokinetics*; D015609:Organotechnetium Compounds / Q000493:pharmacokinetics; D010101:Oxygen Consumption; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D015415:Biomarkers; D009593:Nitroimidazoles; D015609:Organotechnetium Compounds; C082027:BMS 181321